Engineered immune cells take on multiple sclerosis and more
NCT ID NCT07304154
First seen Jan 11, 2026 · Last updated May 01, 2026 · Updated 18 times
Summary
This early-phase study tests a new treatment called KITE-363, which uses a patient's own modified immune cells to target and attack harmful immune cells causing nerve damage. It is for people with relapsed or hard-to-treat autoimmune neurologic diseases like multiple sclerosis, myasthenia gravis, and chronic inflammatory demyelinating polyneuropathy. The main goals are to check safety, find the right dose, and see if it can improve symptoms.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Concord Repatriation General Hospital
RECRUITINGSydney, New South Wales, 2139, Australia
-
Fred Hutchinson Cancer Center
RECRUITINGSeattle, Washington, 98109, United States
-
LDS Hospital - Intermountain Health
RECRUITINGSalt Lake City, Utah, 84143, United States
Conditions
Explore the condition pages connected to this study.